RBC Capital raised the firm’s price target on Veeva (VEEV) to $285 from $275 and keeps an Outperform rating on the shares. The company reported a good beat-and-raise quarter, and while the firm expected this outcome following guidance reaffirmation at the investor day, RBC was still pleased to see full year revenue, subscription revenue, and billings guidance being raised, the analyst tells investors in a research note. Veeva executed well across the board with strong Commercial momentum amidst an unchanged macro environment, the firm added.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VEEV:
- Veeva price target raised to $261 from $207 at Truist
- Veeva price target raised to $290 from $280 at Piper Sandler
- Veeva price target raised to $285 from $275 at Wells Fargo
- Veeva price target raised to $240 from $235 at Scotiabank
- Veeva price target raised to $245 from $220 at Evercore ISI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.